SCR-LIP-000290 · Claim · machine-readable JSON →
In a comparative observational study, 39.6% (21/53) of lipedema patients met ACR 2016 criteria for fibromyalgia, and the comorbid lipedema+fibromyalgia subgroup had significantly higher pain (median VAS 60 vs 27 for lipedema alone, p<0.001) and worse SF-36 quality-of-life scores across all 8 domains.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Comorbidity of lipedema and fibromyalgia; effects on disease severity, pain and health-related quality of life — ÇAKIT et al. (2023) ✓ verified — consistent · cross sectional · 2023 · reading confidence: high
“39,6% (21/53) das pacientes com lipedema preencheram critérios ACR 2016 de FM”
The study directly quantifies the co-occurrence of fibromyalgia in lipedema patients (39.6% met ACR 2016 criteria) and characterizes pain/QoL effects, with results converging with prior studies (34%, 50%). It is observational and unadjusted
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000008